A phase III study of standard fractionation radiotherapy with concurrent high-dose cisplatin versus accelerated fractionation radiotherapy (RT) with panitumumab in patients with locally advanced stage III and IV squamous cell carcinoma of the head and neck (SCCHN) (NCIC Clinical Trials Group HN.6).

Authors

Waldron JN; Parulekar W; O'Sullivan B; Chen BE; Montenegro A; Nabid A; Winquist E; Wright JR; Hay J; Ringash J

AMER SOC CLINICAL ONCOLOGY

May 20, 2012

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Chicago, IL

June 1, 2012

June 6, 2012

JOURNAL OF CLINICAL ONCOLOGY

0732-183X

James Wright